Drawing on extensive historic medical databases and machine learning algorithms, AI is being used in early detection and monitor cancer from scans.
An AI-based software product has received FDA (Food & Drug Administration) clearance for prostate cancer diagnosis.
The product, Paige Prostate, developed by Paige, a leader in AI-based diagnostic software in pathology, analyzes digitized biopsy records and identifies areas that could be cancerous for pathologists to review further.
This is a significant achievement in the field of digital pathology and shows how AI technology advances are successfully addressing and problem-solving the broad range of natural variations in pathology records.
Other companies in the growing field of digital pathology include Deep Lens, Proscia, and PathAI, all developing tech-powered tools to aid diagnosis.